The burden of progressive fibrotic interstitial lung disease across the UK

Almost 15% of new referrals with non-IPF fibrotic ILD go on to develop a progressive fibrotic phenotype and would benefit from antifibrotic therapy https://bit.ly/3uPhClN

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Respir J
Main Authors: Simpson, Thomas, Barratt, Shaney L., Beirne, Paul, Chaudhuri, Nazia, Crawshaw, Anjali, Crowley, Louise E., Fletcher, Sophie, Gibbons, Michael A., Hallchurch, Philippa, Horgan, Laura, Jakaityte, Ieva, Lewis, Thomas, McLellan, Tom, Myall, Katherine J., Miller, Ryan, Smith, David J.F., Stanel, Stefan, Thillai, Muhunthan, Thompson, Fiona, Wallis, Timothy, Wu, Zhe, Molyneaux, Philip L., West, Alex G.
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2021
Assuntos:
Agora
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264777/
https://ncbi.nlm.nih.gov/pubmed/33678609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00221-2021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados